QQQ $ 475.98 $ -3.95 (-0.82 %)
DIA $ 413.10 $ 0.25 (0.06 %)
SPY $ 561.43 $ -1.76 (-0.31 %)
TLT $ 98.25 $ -0.40 (-0.41 %)
GLD $ 232.93 $ -0.55 (-0.24 %)
$ 1.43
-- x --
-- x --
-- - --
$ 0.80 - $ 3.50
1,846
na
1.49M
$ -26.45
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2024 06-30-2024 10-Q
2 05-15-2024 03-31-2024 10-Q
3 04-01-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-12-2023 03-31-2023 10-Q
7 03-14-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-10-2022 06-30-2022 10-Q
10 05-11-2022 03-31-2022 10-Q
11 03-25-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
13 08-11-2021 06-30-2021 10-Q
14 05-11-2021 03-31-2021 10-Q
15 03-16-2021 12-31-2020 10-K
16 11-12-2020 09-30-2020 10-Q
17 08-11-2020 06-30-2020 10-Q
18 05-15-2020 03-31-2020 10-Q
19 03-25-2020 12-31-2019 10-K
20 11-12-2019 09-30-2019 10-Q
21 08-12-2019 06-30-2019 10-Q
22 05-15-2019 03-31-2019 10-Q
23 03-28-2019 12-31-2018 10-K
24 11-08-2018 09-30-2018 10-Q
25 08-09-2018 06-30-2018 10-Q
26 05-10-2018 03-31-2018 10-Q
27 03-12-2018 12-31-2017 10-K
28 11-09-2017 09-30-2017 10-Q
29 08-11-2017 06-30-2017 10-Q
30 05-12-2017 03-31-2017 10-Q
31 03-30-2017 12-31-2016 10-K
32 11-18-2016 09-30-2016 10-Q
33 08-08-2016 06-30-2016 10-Q
34 05-16-2016 03-31-2016 10-Q
35 03-29-2016 12-31-2015 10-K
36 11-12-2015 09-30-2015 10-Q
37 08-13-2015 06-30-2015 10-Q
38 05-14-2015 03-31-2015 10-Q
39 03-25-2015 12-31-2014 10-K
40 11-14-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 yield10-bioscience-q1-2024-adj-eps-477-misses-264-estimate-sales-30000k-miss-188m-estimate

Yield10 Bioscience (NASDAQ:YTEN) reported quarterly losses of $(4.77) per share which missed the analyst consensus estimate of ...

 yield10-bioscience-has-received-a-notice-of-allowance-for-its-us-patent-application-17273159-titled-genetically-engineered-land-plants-that-express-an-increased-seed-yield-protein-andor-an-increased-seed-yield-rna

Patent Center (uspto.gov) 

 yield10-bioscience-filed-formrw-registration-statement-has-not-been-declared-effective-by-the-commission-registrant-confirms-that-no-securities-have-been-sold

- SEC Filing

 why-stryve-foods-shares-are-trading-lower-by-around-25-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.

 yield10-bioscience-q4-eps-027-beats-030-estimate

Yield10 Bioscience (NASDAQ:YTEN) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(...

 earnings-scheduled-for-april-1-2024

Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per...

 yield10-bioscience-announces-that-the-plant-biosafety-office-of-the-canadian-food-inspection-agency-has-cleared-genome-edited-e3902-camelina-for-planting-in-canada

Yield10 Bioscience, Inc. (NASDAQ:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION